PE-VC background remains critical for pre-revenue biotech IPOs, says HKEX executive

Christina Bao, managing director and co-head of sales & marketing at the Hong Kong Exchanges and Clearing (HKEX)

Printed by Unregistered user on Sat, 02 Aug 2025 20:55:51 GMT